TABLE 3.

Hierarchical regression analyses predicting changes in ECP concentrations and changes in IL-4 productions from parental depressive symptoms (CES-D).

		β	t	p	ΔR2	ΔF	df1,df2	ΔFp
1	ECP visit 1	.52	5.50	<.001*	.272	30.29	1,81	<.001*
	asthma severity	−.08	−0.81	.42
2	icsa	.23	1.31	.20	.031	1.14	3,78	.34
	β-agonists	−.11	−0.65	.52
3	group	−.18	−0.82	.42	.006	0.67	1,77	.42
4	CES-D	.19	2.03	.046*	.036	4.13	1,76	.046*
5	CES-D-by-group	−.17	−1.56	.12	.021	2.43	1,75	.12
1	IL-4 visit 1	.01	0.09	.93	.000	0.01	1,74	.93
	asthma severity	−.05	−0.42	.68
2	icsa	−.12	−0.57	.57	.010	0.25	3,71	.86
	β-agonists	.02	0.09	.93
3	group	−.16	−0.56	.58	.004	0.31	1,70	.58
4	CES-D	.16	1.31	.19	.024	1.72	1,69	.19
5	CES-D-by-group	.01	0.05	.96	.000	0.00	1,68	.96

^*p<.05

⁺p<.10

^ainhaled corticosteroids